Standardized cannabis medicine – The ‘responsibility of all in the industry’


Creating standardized medicine is the gold standard for the cannabis industry but the nature of the plant can make this difficult, attendees to Cannabis Europa heard. Some panelists argued that attempts by the major pharmaceutical companies to patent drugs from the cannabis plant should be challenged. Others said that for cannabis medicine to achieve globally accepted standards there would need to be an involvement from the pharmaceutical giants to fund the research. Dr Barbara Pacchetti, of U.K. company EMMAC Life Sciences, described cannabis as an ‘unconventional medicine’. “The aim is for standardized cannabis medicine, and this would be the peak…
Source: 4:20intel.com
Standardized cannabis medicine – The ‘responsibility of all in the industry’